Glanzmann's thrombasthenia differential diagnosis: Difference between revisions

	Glanzmann's thrombasthenia
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Glanzmann's thrombasthenia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Echocardiography and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Glanzmann's thrombasthenia differential diagnosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Glanzmann's thrombasthenia differential diagnosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Glanzmann's thrombasthenia differential diagnosis
CDC on Glanzmann's thrombasthenia differential diagnosis
Glanzmann's thrombasthenia differential diagnosis in the news
Blogs on Glanzmann's thrombasthenia differential diagnosis
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Glanzmann's thrombasthenia differential diagnosis

VisualWikitext

Revision as of 18:46, 13 November 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Omer Kamal, M.D.[2], Niyousha Danesh, MD-MPH

Overview

Glanzmann thrombasthenia must be differentiated from other diseases that cause severe hemorrhages , mucocutaneous bleeding , petechiae and ecchymosis, such as platelet Disorders (like : Bernard-Soulier syndrome,platelet storage pool defects,platelet-type von Willebrand disease and gray platelet syndrome), Fibrinogen abnormalities ,(eg Afibrinogenemia), Von Willebrand Disease and Wiskott-Aldrich Syndrome.

Differential Diagnoses

platelet Disorders (like : Bernard-Soulier syndrome,platelet storage pool defects,platelet-type von Willebrand disease and gray platelet syndrome),
Von Willebrand Disease and
Wiskott-Aldrich Syndrome.
Fibrinogen abnormalities ,(eg Afibrinogenemia)

Differential Diagnosis

Diseases	Laboratory Findings					Physical Examination				History and Symptoms						Treatment
Diseases	Bleeding Time (BT)	PT	aPTT	Platelet count	vWF	Petechiae & Purpura	Ecchymosis	Mucocutaneous hemorrhage	Severe fatal bleeding	Epistaxis	Oral bleeding	Menorrhagia & Postpartum hemorrhage	Infection	Hemarthrosis	Additional information	Treatment
Glanzmann Thrombasthenia^[1]	↑	Normal (Nl)	Nl	lower level of Normal	Nl	+	+	+	+	+	+	+	_	_	Autosomal recessive (AR) GpIIb/IIIa receptor defect ITGA2B and ITGB3 gene Platelet aggregation responds to ristocetin but not (ADP), epinephrine, and collagen.	Local hemostatic procedures Anti-fibrinolytic drugs rFVIIa, IVIG, plasmapheresis, corticosteroids, rituximab HSCT^[2]
Von Willebrand disease (vWD)	Nl	Nl	↑	Nl	↓	+	+	+	+	+	+	+	_	_	Autosomal dominant (AD) and autosomal recessive, AR (rare)	vWF DDAVP factor VIII concentrates^[3]
Bernard-Soulier Syndrome^[4]	↑	↓	Nl	↓ giant platelets	↑	+	+	+	+	+	+	+	_	_	AR ↓GPIb/IX/V platelets platelets do not aggregate in response to ristocetin but responds to ADP, epinephrine, and collagen	DDAVP antifibrinolytic rFVIIa^[5]
Wiskott-Aldrich Syndrome^[6]	Nl	Nl	Nl	↓ microthrombocytopenia	Nl	+	+	↓	+ (specially GI bleeding)	+	↓	↓	+	_	X-linked defect in The WASp gene +Severe eczema	antibiotics, antivirals, antifungals, chemotherapy immunoglobulins corticosteroids
Inherited Abnormalities of Fibrinogen^[7]	↑	↑	↑	Nl	↓	Inherited Abnormalities of Fibrinogen	+	+	+	+	+	+	_	+	Fibrinogen defect 3gene:FGA, FGB, and FGG	Fibrinogen concentrates cryoprecipitate^[8]

References

↑ Nurden AT (2006). "Glanzmann thrombasthenia". Orphanet J Rare Dis. 1: 10. doi:10.1186/1750-1172-1-10. PMC 1475837. PMID 16722529.
↑ Solh T, Botsford A, Solh M (2015). "Glanzmann's thrombasthenia: pathogenesis, diagnosis, and current and emerging treatment options". J Blood Med. 6: 219–27. doi:10.2147/JBM.S71319. PMC 4501245. PMID 26185478.
↑ de Wee EM, Sanders YV, Mauser-Bunschoten EP, van der Bom JG, Degenaar-Dujardin ME, Eikenboom J; et al. (2012). "Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease". Thromb Haemost. 108 (4): 683–92. doi:10.1160/TH12-04-0244. PMID 22918553.
↑ Pham A, Wang J (2007). "Bernard-Soulier syndrome: an inherited platelet disorder". Arch Pathol Lab Med. 131 (12): 1834–6. doi:10.1043/1543-2165(2007)131[1834:BSAIPD]2.0.CO;2. PMID 18081445.
↑ Diz-Küçükkaya R (2013). "Inherited platelet disorders including Glanzmann thrombasthenia and Bernard-Soulier syndrome". Hematology Am Soc Hematol Educ Program. 2013: 268–75. doi:10.1182/asheducation-2013.1.268. PMID 24319190.
↑ Ochs HD, Thrasher AJ (2006). "The Wiskott-Aldrich syndrome". J Allergy Clin Immunol. 117 (4): 725–38, quiz 739. doi:10.1016/j.jaci.2006.02.005. PMID 16630926.
↑ Zhou J, Ding Q, Chen Y, Ouyang Q, Jiang L, Dai J; et al. (2015). "Clinical features and molecular basis of 102 Chinese patients with congenital dysfibrinogenemia". Blood Cells Mol Dis. 55 (4): 308–15. doi:10.1016/j.bcmd.2015.06.002. PMID 26460252.
↑ Verhovsek M, Moffat KA, Hayward CP (2008). "Laboratory testing for fibrinogen abnormalities". Am J Hematol. 83 (12): 928–31. doi:10.1002/ajh.21293. PMID 18951466.

[pmid16722529-1] Nurden AT (2006). "Glanzmann thrombasthenia". Orphanet J Rare Dis. 1: 10. doi:10.1186/1750-1172-1-10. PMC 1475837. PMID 16722529.

[pmid26185478-2] Solh T, Botsford A, Solh M (2015). "Glanzmann's thrombasthenia: pathogenesis, diagnosis, and current and emerging treatment options". J Blood Med. 6: 219–27. doi:10.2147/JBM.S71319. PMC 4501245. PMID 26185478.

[pmid22918553-3] Wee EM, Sanders YV, Mauser-Bunschoten EP, van der Bom JG, Degenaar-Dujardin ME, Eikenboom J; et al. (2012). "Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease". Thromb Haemost. 108 (4): 683–92. doi:10.1160/TH12-04-0244. PMID 22918553.

[pmid18081445-4] Pham A, Wang J (2007). "Bernard-Soulier syndrome: an inherited platelet disorder". Arch Pathol Lab Med. 131 (12): 1834–6. doi:10.1043/1543-2165(2007)131[1834:BSAIPD]2.0.CO;2. PMID 18081445.

[pmid24319190-5] Diz-Küçükkaya R (2013). "Inherited platelet disorders including Glanzmann thrombasthenia and Bernard-Soulier syndrome". Hematology Am Soc Hematol Educ Program. 2013: 268–75. doi:10.1182/asheducation-2013.1.268. PMID 24319190.

[pmid16630926-6] Ochs HD, Thrasher AJ (2006). "The Wiskott-Aldrich syndrome". J Allergy Clin Immunol. 117 (4): 725–38, quiz 739. doi:10.1016/j.jaci.2006.02.005. PMID 16630926.

[pmid26460252-7] Zhou J, Ding Q, Chen Y, Ouyang Q, Jiang L, Dai J; et al. (2015). "Clinical features and molecular basis of 102 Chinese patients with congenital dysfibrinogenemia". Blood Cells Mol Dis. 55 (4): 308–15. doi:10.1016/j.bcmd.2015.06.002. PMID 26460252.

[pmid18951466-8] Verhovsek M, Moffat KA, Hayward CP (2008). "Laboratory testing for fibrinogen abnormalities". Am J Hematol. 83 (12): 928–31. doi:10.1002/ajh.21293. PMID 18951466.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

@@ Line 2: / Line 2: @@
 {{Glanzmann's thrombasthenia}}
-{{CMG}} '''Associate Editor(s)-in-Chief:''' [[User:Niush.D|Niyousha Danesh, MD-MPH]]
+{{CMG}}, {{AE}} {{OK}}, [[User:Niush.D|Niyousha Danesh, MD-MPH]]
 ==Overview==